Lymphedema after breast cancer treatment

乳腺癌治疗后淋巴水肿

• 批准号: 6405721
• 负责人: Sheila H Ridner
• 金额: $ 4.13万
• 依托单位: VANDERBILT UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-08-02 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/6405721
• 关键词: breast neoplasms; combination therapy; female; functional ability; human subject; human therapy evaluation; immunopathology therapy; lymphedema; mental health; neoplasm /cancer therapy; pain; pathologic process; patient care management; patient oriented research; predoctoral investigator; quality of life; self concept; sex behavior; touch; women's health

The proposed research training plan in this level 1 application will address the problem of lymphedema following breast cancer treatment. Training plan specific aims are to: 1) describe the physiological and pathophysiological processes relative to lymphedema; 2) critically review and synthesize theory and research related to lymphedema specifically and cancer symptom management more generally; 3) identify valid and reliable lymphedema measurement methods that can be feasibly implemented in outpatient oncology settings; 4) evaluate current treatment modalities for lymphedema; 5) examine biopsychosocial outcomes potentially related to lymphedema (e.g. altered touch, fine or gross motor movement, and sexuality); and 6) perform independent research in this area. The research question is: What is the short-term effectiveness of a multi-modal treatment regimen on reducing lymphedema and improving quality of life (QOL) outcomes when given as a first line treatment for breast cancer survivors? Research specific aims are to: 1) examine the short-term effectiveness of a multi-modal treatment regimen on reducing lymphedema when given as a first line treatment to breast cancer survivors; 2) examine tolerance to the multi-modal treatment regimen when given as a first line treatment to breast cancer survivors; 3) assess QOL outcomes associated with reduction of lymphedema.

在这个一级申请中提出的研究培训计划将解决乳腺癌治疗后淋巴水肿的问题。训练计划的具体目标是：1)描述与淋巴水肿相关的生理和病理生理过程；2)批判性地回顾和综合与淋巴水肿和癌症症状管理相关的理论和研究；3)确定有效和可靠的淋巴水肿测量方法，可在门诊肿瘤科实施；4)评价目前淋巴水肿的治疗方式；5)检查可能与淋巴水肿相关的生物心理社会结果（如触觉改变、精细或大运动和性行为）；6)在该领域进行独立研究。研究的问题是：当作为乳腺癌幸存者的一线治疗时，多模式治疗方案在减少淋巴水肿和改善生活质量（QOL）结果方面的短期有效性是什么？研究的具体目的是：1)检查多模式治疗方案作为一线治疗对乳腺癌幸存者减少淋巴水肿的短期有效性；2)检查多模式治疗方案作为一线治疗给予乳腺癌幸存者时的耐受性；3)评估与淋巴水肿减少相关的生活质量。